Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Adenocarcinoma × Brachytherapy × Clear all

Phase

Status

Withdrawn 1 Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 16 Prostatic Neoplasms 6 Neoplasms 2 Uveitis 1 Uveal Melanoma 1 Uterine Cervical Dysplasia 1 To Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer 1 Sarcoma 1 Salivary Gland Neoplasms 1 Precancerous Conditions 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Obesity 1 Neurotoxicity Syndromes 1 Liver Neoplasms 1 Hyperthermia 1 Gliosarcoma 1 Glioblastoma 1 Fatigue 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation 1 Endometrial Clear Cell Adenocarcinoma 1 Deglutition Disorders 1 Choroid Neoplasms 1 Central Nervous System Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

Capecitabine 5 Pemetrexed 4 Docetaxel 4 pembrolizumab 2 icotinib 2 Oxaliplatin 2 Gemcitabine 2 Gefitinib 2 Drug Therapy 2 Chemoradiotherapy 2 sintilimab 1 rucaparib 1 regorafenib 1 lenvatinib 1 iron isomaltoside 1000 1 ipatasertib 1 iopromide 1 gluconic acid 1 atezolizumab 1 anlotinib 1 XELOX 1 Trastuzumab 1 Telemedicine 1 Surveys and Questionnaires 1 Sorafenib 1 S 1 (combination) 1 Registries 1 Ramucirumab 1 Radiotherapy 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01786278 2013-02-07

BRASTEGAC

Medical University of Lublin

Phase 2/3 Unknown

Adenocarcinoma, Deglutition Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡